CWMS
KYNB

CFG Wealth Management Services’s Kyntra Bio KYNB Stock Holding History

CFG Wealth Management Services’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$20 – 106
2026
Q1 		$20 Hold
3
– – ﹤0.01% 152
2025
Q4 		$26 Buy
+3
New +$29 ﹤0.01% 157

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

CFG Wealth Management Services's KYNB Position: Q2 2026 in Review

CFG Wealth Management Services sold out of Kyntra Bio (KYNB) in Q2 2026, closing a stake of 3 shares — an estimated $20 sold.

CFG Wealth Management Services first reported a position in KYNB in Q4 2025 and held it in 2 quarters. The position peaked at $26 in Q4 2025. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • CFG Wealth Management Services reported no remaining Kyntra Bio position as of Q2 2026 after selling out during the quarter.
  • CFG Wealth Management Services sold 3 Kyntra Bio shares in Q2 2026, an estimated $20.
  • CFG Wealth Management Services first reported a position in Kyntra Bio in Q4 2025 and held it in 2 quarters.
  • CFG Wealth Management Services's Kyntra Bio position peaked at $26 in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on CFG Wealth Management Services's 13F filing for Q2 2026, filed 15 Jul 2026.